Abstract
One of the clinical indications for administering cholinesterase inhibitors, or anticholinesterases, is to reverse the effect of muscle relaxation by non-depolarizing neuromuscular blocking agents at the conclusion of surgery. The purpose of administering antimuscarinic drugs concomitantly with anticholinesterases is to minimize the muscarinic side effects associated with increased acetylcholine transmission at muscarinic receptors. In this chapter, we review anticholinesterase and anticholinergic pharmacology, including mechanism of action, dosing, and adverse effects. We discuss their clinical significance in both the surgical context and their indications outside the operating room. In addition, we briefly discuss the relaxant binding agent sugammadex and its future role in anesthesia.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Glick DB. The autonomic nervous system. In: Miller RD, editor. Miller’s anesthesia. 7th ed. Orlando: Churchill Livingstone; 2009.
Pohanka M. Acetylcholinesterase inhibitors; a patent review (2008-present). Expert Opin Ther Pat. 2012;22:871–86. doi:10.1517/13543776.2012.701620.
Naguib M, Lien CA. Pharmacology of muscle relaxants and their antagonists. In: Miller RD, editor. Miller’s anesthesia. 7th ed. Orlando: Churchill Livingstone; 2009.
Donati F, Bevan DR. Neuromuscular blocking agents. In: Barash PG, editor. Clinical anesthesia. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2009.
Katzung BG. Cholinoceptor-blocking drugs. In: Basic and clinical pharmacology. 12th ed. New York: McGraw-Hill; 2011.
Morgan GE, Mikhail MS. Cholinesterase inhibitors. In: Clinical anesthesiology. 4th ed. New York: McGraw-Hill; 2006.
Bevan JC, Collins L, Fowler C, et al. Early and late reversal of rocuronium and vecuronium with neostigmine in adults and children. Anesth Analg. 1999;89:333–9.
Caldwell JE. Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium. Anesth Analg. 1995;80:1168–74.
Saitoh Y, Toyooka H, Amaha K. Recoveries of post-tetanic twitch and train-of-four responses after administration of vecuronium with different inhalation anaesthetics and neuroleptanaesthesia. Br J Anaesth. 1993;70:402–4.
Baurain MJ, D’Hollander AA, Melot C, et al. Effects of residual concentrations of isoflurane on the reversal of vecuronium-induced neuromuscular blockade. Anesthesiology. 1991;74:474–8.
Burkett L, Bikhazi GZB, Thomas Jr KC, et al. Mutual potentiation of the neuromuscular effects of antibiotics and relaxants. Anesth Analg. 1979;58:107–15.
Sinatra RS, Philip BK, Naulty JS, Ostheimer GW. Prolonged neuromuscular blockade with vecuronium in a patient treated with magnesium sulfate. Anesth Analg. 1985;64:1220–2.
Usubiaga JE, Wikinski JA, Morales RL. Interaction of intravenously administered procaine, lidocaine and succinylcholine in anesthetized subjects. Anesth Analg. 1967;46:39–45.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Chemical Structures
Chemical Structure 13.1
Neostigmine
Chemical Structure 13.2
Physostigmine
Chemical Structure 13.3
Pyridostigmine
Chemical Structure 13.4
Acetylcholine
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
Sim, A., Vick, A. (2015). Reversal Agents. In: Kaye, A., Kaye, A., Urman, R. (eds) Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-8948-1_13
Download citation
DOI: https://doi.org/10.1007/978-1-4614-8948-1_13
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-8947-4
Online ISBN: 978-1-4614-8948-1
eBook Packages: MedicineMedicine (R0)